You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease

€3.03

SKU: product-article-16320 Category: General

Description
Reviews (0)

Description

PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease

Reviews

There are no reviews yet.

Be the first to review “Article: PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease”

You must be logged in to post a review.

Top

Article: PP51 Impact of Th17 cell population on xenogeneic graft-versus-host disease

Description

Reviews

Related products

Article: INTRODUCTION

Article: Highlights in urologic cancer

Article: INTRODUCTION

Article: Calendar of events